GlassScriptPhysician profile
David M Allen
NPI 1982746863
$1,627.26
in general payments reported to CMS, 2019-2025
22 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $295 · 2021: $177 · 2022: $398 · 2023: $91.04 · 2024: $184 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $409.69 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $332.82 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $132.58 | 2019-2024 | Renasys Touch, Collagenase Santyl |
| Merck Sharp & Dohme LLC | $123.38 | 2019 | |
| Organogenesis INC. | $109.33 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Heron Therapeutics, INC. | $72.47 | 2022 | |
| Nevro Corp. | $64.38 | 2024 | Senza |
| Globus Medical, INC. | $30.09 | 2025 | Senza |
| Surgenex LLC | $28.06 | 2025 | Surmatrix, Renograft, Ardeograft |
| Melinta Therapeutics, LLC | $27.83 | 2019 | |
| Biowound Solutions, INC. | $26.01 | 2025 | Bio-Connekt |
| Kerecis Limited | $23.44 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Averitas Pharma INC. | $21.40 | 2024 | Qutenza |
| Reprise Biomedical, INC. | $20.92 | 2024 | Miro3d |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $20.02 | 2019 | |
| Boston Scientific Corporation | $17.37 | 2019 | |
| Integra Lifesciences Corporation | $15.98 | 2020 | |
| Orthofix Medical, INC. | $15.62 | 2021 | |
| Hartmann USA, INC. | $14.45 | 2021 | |
| Ermi LLC | $13.82 | 2019 | |
| Grt US Holding, INC. | $7.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.